vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $78.6M, roughly 1.6× Repay Holdings Corp). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -178.3%, a 181.6% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs 0.4%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -1.3%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
NATR vs RPAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $78.6M |
| Net Profit | $4.1M | $-140.1M |
| Gross Margin | 72.5% | 74.2% |
| Operating Margin | 4.3% | -182.2% |
| Net Margin | 3.3% | -178.3% |
| Revenue YoY | 4.7% | 0.4% |
| Net Profit YoY | 1379.4% | -3304.1% |
| EPS (diluted) | $0.23 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $78.6M | ||
| Q3 25 | $128.3M | $77.7M | ||
| Q2 25 | $114.8M | $75.6M | ||
| Q1 25 | $113.2M | $77.3M | ||
| Q4 24 | $118.2M | $78.3M | ||
| Q3 24 | $114.6M | $79.1M | ||
| Q2 24 | $110.6M | $74.9M | ||
| Q1 24 | $111.0M | $80.7M |
| Q4 25 | $4.1M | $-140.1M | ||
| Q3 25 | $5.3M | $-6.4M | ||
| Q2 25 | $5.3M | $-102.3M | ||
| Q1 25 | $4.7M | $-7.9M | ||
| Q4 24 | $-321.0K | $-4.1M | ||
| Q3 24 | $4.3M | $3.2M | ||
| Q2 24 | $1.3M | $-4.1M | ||
| Q1 24 | $2.3M | $-5.2M |
| Q4 25 | 72.5% | 74.2% | ||
| Q3 25 | 73.3% | 74.4% | ||
| Q2 25 | 71.7% | 75.7% | ||
| Q1 25 | 72.1% | 75.9% | ||
| Q4 24 | 72.0% | 76.3% | ||
| Q3 24 | 71.3% | 77.8% | ||
| Q2 24 | 71.4% | 78.2% | ||
| Q1 24 | 71.2% | 76.2% |
| Q4 25 | 4.3% | -182.2% | ||
| Q3 25 | 7.0% | -3.9% | ||
| Q2 25 | 3.7% | -138.7% | ||
| Q1 25 | 5.4% | -4.7% | ||
| Q4 24 | 3.8% | -1.5% | ||
| Q3 24 | 4.6% | -0.9% | ||
| Q2 24 | 5.1% | -4.6% | ||
| Q1 24 | 4.2% | -3.1% |
| Q4 25 | 3.3% | -178.3% | ||
| Q3 25 | 4.2% | -8.3% | ||
| Q2 25 | 4.6% | -135.2% | ||
| Q1 25 | 4.2% | -10.3% | ||
| Q4 24 | -0.3% | -5.3% | ||
| Q3 24 | 3.8% | 4.1% | ||
| Q2 24 | 1.2% | -5.4% | ||
| Q1 24 | 2.1% | -6.5% |
| Q4 25 | $0.23 | $-1.68 | ||
| Q3 25 | $0.30 | $-0.08 | ||
| Q2 25 | $0.28 | $-1.15 | ||
| Q1 25 | $0.25 | $-0.09 | ||
| Q4 24 | $-0.02 | $-0.04 | ||
| Q3 24 | $0.23 | $0.03 | ||
| Q2 24 | $0.07 | $-0.04 | ||
| Q1 24 | $0.12 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $115.7M |
| Total DebtLower is stronger | — | $280.1M |
| Stockholders' EquityBook value | $161.6M | $484.4M |
| Total Assets | $261.1M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $115.7M | ||
| Q3 25 | $95.6M | $95.7M | ||
| Q2 25 | $81.3M | $162.6M | ||
| Q1 25 | $86.5M | $165.5M | ||
| Q4 24 | $84.7M | $189.5M | ||
| Q3 24 | $78.7M | $168.7M | ||
| Q2 24 | $68.7M | $147.1M | ||
| Q1 24 | $77.8M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | $2.1M | $434.9M |
| Q4 25 | $161.6M | $484.4M | ||
| Q3 25 | $166.7M | $616.9M | ||
| Q2 25 | $163.7M | $633.7M | ||
| Q1 25 | $167.1M | $755.7M | ||
| Q4 24 | $161.0M | $761.3M | ||
| Q3 24 | $162.6M | $754.7M | ||
| Q2 24 | $156.4M | $815.4M | ||
| Q1 24 | $159.7M | $813.8M |
| Q4 25 | $261.1M | $1.2B | ||
| Q3 25 | $264.8M | $1.3B | ||
| Q2 25 | $254.9M | $1.4B | ||
| Q1 25 | $252.7M | $1.5B | ||
| Q4 24 | $240.9M | $1.6B | ||
| Q3 24 | $245.3M | $1.6B | ||
| Q2 24 | $235.8M | $1.5B | ||
| Q1 24 | $247.3M | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | 0.01× | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $23.3M |
| Free Cash FlowOCF − Capex | $7.6M | $23.2M |
| FCF MarginFCF / Revenue | 6.1% | 29.6% |
| Capex IntensityCapex / Revenue | 1.9% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $23.3M | ||
| Q3 25 | $18.5M | $32.2M | ||
| Q2 25 | $4.3M | $33.1M | ||
| Q1 25 | $2.6M | $2.5M | ||
| Q4 24 | $12.2M | $34.3M | ||
| Q3 24 | $9.6M | $60.1M | ||
| Q2 24 | $1.3M | $31.0M | ||
| Q1 24 | $2.2M | $24.8M |
| Q4 25 | $7.6M | $23.2M | ||
| Q3 25 | $16.8M | $32.1M | ||
| Q2 25 | $3.0M | $33.0M | ||
| Q1 25 | $1.5M | $2.4M | ||
| Q4 24 | $10.0M | $34.0M | ||
| Q3 24 | $7.9M | $59.8M | ||
| Q2 24 | $-2.0M | $30.5M | ||
| Q1 24 | $-1.5M | $24.7M |
| Q4 25 | 6.1% | 29.6% | ||
| Q3 25 | 13.1% | 41.3% | ||
| Q2 25 | 2.6% | 43.6% | ||
| Q1 25 | 1.3% | 3.0% | ||
| Q4 24 | 8.5% | 43.5% | ||
| Q3 24 | 6.9% | 75.6% | ||
| Q2 24 | -1.9% | 40.7% | ||
| Q1 24 | -1.4% | 30.6% |
| Q4 25 | 1.9% | 0.1% | ||
| Q3 25 | 1.3% | 0.2% | ||
| Q2 25 | 1.2% | 0.1% | ||
| Q1 25 | 1.0% | 0.2% | ||
| Q4 24 | 1.9% | 0.3% | ||
| Q3 24 | 1.5% | 0.3% | ||
| Q2 24 | 3.0% | 0.6% | ||
| Q1 24 | 3.3% | 0.1% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | 18.52× | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
